REPORT ID 2721

United States Fibrinogen Concentrates Market Report 2017

Publish Date
11-Dec-17
Pages
107
Format
Electronic (PDF)

In this report, the United States Fibrinogen Concentrates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Fibrinogen Concentrates in these regions, from 2012 to 2022 (forecast).

United States Fibrinogen Concentrates market competition by top manufacturers/players, with Fibrinogen Concentrates sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    CSL Behring
    Baxter
    Johnson & Johnson (Ethicon)
    LFB Group
    ProFibrix BV (The Medicines Company)
    Shanghai RAAS
    Jiangxi Boya Bio-Pharmaceutical
    Hualan Biological Engineering
    Harbin Pacific Biopharmaceutical
    Greencross
    Shanghai XinXing Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Human Fibrinogen Concentrate
    Animal Fibrinogen Concentrate
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Congenital Fibrinogen Deficiency
    Surgical Procedures

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Fibrinogen Concentrates Market Report 2017
1 Fibrinogen Concentrates Overview
    1.1 Product Overview and Scope of Fibrinogen Concentrates
    1.2 Classification of Fibrinogen Concentrates by Product Category
        1.2.1 United States Fibrinogen Concentrates Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Fibrinogen Concentrates Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Human Fibrinogen Concentrate
        1.2.4 Animal Fibrinogen Concentrate
    1.3 United States Fibrinogen Concentrates Market by Application/End Users
        1.3.1 United States Fibrinogen Concentrates Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Congenital Fibrinogen Deficiency
        1.3.3 Surgical Procedures
    1.4 United States Fibrinogen Concentrates Market by Region
        1.4.1 United States Fibrinogen Concentrates Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Fibrinogen Concentrates Status and Prospect (2012-2022)
        1.4.3 Southwest Fibrinogen Concentrates Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Fibrinogen Concentrates Status and Prospect (2012-2022)
        1.4.5 New England Fibrinogen Concentrates Status and Prospect (2012-2022)
        1.4.6 The South Fibrinogen Concentrates Status and Prospect (2012-2022)
        1.4.7 The Midwest Fibrinogen Concentrates Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Fibrinogen Concentrates (2012-2022)
        1.5.1 United States Fibrinogen Concentrates Sales and Growth Rate (2012-2022)
        1.5.2 United States Fibrinogen Concentrates Revenue and Growth Rate (2012-2022)

2 United States Fibrinogen Concentrates Market Competition by Players/Suppliers
    2.1 United States Fibrinogen Concentrates Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Fibrinogen Concentrates Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Fibrinogen Concentrates Average Price by Players/Suppliers (2012-2017)
    2.4 United States Fibrinogen Concentrates Market Competitive Situation and Trends
        2.4.1 United States Fibrinogen Concentrates Market Concentration Rate
        2.4.2 United States Fibrinogen Concentrates Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Fibrinogen Concentrates Manufacturing Base Distribution, Sales Area, Product Type

3 United States Fibrinogen Concentrates Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Fibrinogen Concentrates Sales and Market Share by Region (2012-2017)
    3.2 United States Fibrinogen Concentrates Revenue and Market Share by Region (2012-2017)
    3.3 United States Fibrinogen Concentrates Price by Region (2012-2017)

4 United States Fibrinogen Concentrates Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Fibrinogen Concentrates Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Fibrinogen Concentrates Revenue and Market Share by Type (2012-2017)
    4.3 United States Fibrinogen Concentrates Price by Type (2012-2017)
    4.4 United States Fibrinogen Concentrates Sales Growth Rate by Type (2012-2017)

5 United States Fibrinogen Concentrates Sales (Volume) by Application (2012-2017)
    5.1 United States Fibrinogen Concentrates Sales and Market Share by Application (2012-2017)
    5.2 United States Fibrinogen Concentrates Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Fibrinogen Concentrates Players/Suppliers Profiles and Sales Data
    6.1 CSL Behring
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 CSL Behring Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Baxter
        6.2.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Baxter Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson & Johnson (Ethicon)
        6.3.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson & Johnson (Ethicon) Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 LFB Group
        6.4.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 LFB Group Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 ProFibrix BV (The Medicines Company)
        6.5.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 ProFibrix BV (The Medicines Company) Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Shanghai RAAS
        6.6.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Shanghai RAAS Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Jiangxi Boya Bio-Pharmaceutical
        6.7.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Hualan Biological Engineering
        6.8.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Hualan Biological Engineering Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Harbin Pacific Biopharmaceutical
        6.9.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Harbin Pacific Biopharmaceutical Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Greencross
        6.10.2 Fibrinogen Concentrates Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Greencross Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Shanghai XinXing Medical

7 Fibrinogen Concentrates Manufacturing Cost Analysis
    7.1 Fibrinogen Concentrates Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Fibrinogen Concentrates

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Fibrinogen Concentrates Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Fibrinogen Concentrates Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Fibrinogen Concentrates Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Fibrinogen Concentrates Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Fibrinogen Concentrates Sales Volume Forecast by Type (2017-2022)
    11.3 United States Fibrinogen Concentrates Sales Volume Forecast by Application (2017-2022)
    11.4 United States Fibrinogen Concentrates Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer